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METHODS: A randomized, prospective, parallel, dou-
ble-blind, double-dummy trial was conducted to deter-
mine the analgesic efficacy and time to onset of analgesia
following IV and IM administration of ketorolac (15 mg
and 30 mg), and oral ibuprofen 800 mg (N  100). Pain
intensity was evaluated using visual analog and verbal
rating scales. 
RESULTS: Patients who received ketorolac (30 mg IV)
showed a greater decrease in pain intensity compared with
patients in all other groups (p  0.005). Fifty percent pain
relief before the end of the study was achieved by 50% of
patients in one group only: ketorolac (30 mg IV). 
CONCLUSION: Ketorolac (30 mg IV) provided a greater
degree of pain relief and a quicker time to onset of analge-
sia than all other groups. There were no differences in an-
algesic efficacy between ketorolac (30 mg IM), ketorolac
(15 mg IM), ketorolac (15 mg IV) and ibuprofen 800 mg.
ECONOMIC AND OUTCOMES ISSUES OF 
WOMEN’S AND MEN’S HEALTH DISORDERS
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OBJECTIVE: The purpose of this study was to compare
the 5-year costs of using various sequences of contracep-
tive methods. 
METHOD: We constructed a series of 20 Markov mod-
els, each describing a different sequence of contraceptive
choices over a 5-year time horizon, including one or
more oral contraceptives (COC or POP), Depo Provera,
the Copper IUD (Multiload Cu375 or Nova T), Mirena
and male or female sterilization as a backup option. 
RESULTS: Contraceptive sequences incorporating Mirena
are substantially more effective than those with the stan-
dard copper IUD at little or no additional cost to the
healthcare payer over a 5-year period, whether Mirena is
used as a first-line or second-line contraceptive method.
The higher up-front acquisition cost of the device com-
pared with the standard copper IUD is compensated by its
greater effectiveness in reducing the incidence of costly un-
planned pregnancy. Contraceptive sequences with Mirena,
Depo Provera or the IUD first-line are more effective and
less costly than sequences beginning with oral contracep-
tives first-line. Compared with no contraceptive method,
Mirena has the potential to realise net savings to the
Health Funding Authority of about $2200 per woman
over a 5-year period through preventing costly unplanned
pregnancy. 
CONCLUSIONS: These findings support Mirena either as
first-line contraception for women who have completed
their families or as a second-line contraceptive method for
women for whom the IUD or oral contraception is inap-
propriate or who cannot tolerate other methods.
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FROM A PHARMACIST IN WASHINGTON STATE
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OBJECTIVE: The purpose of this analysis was to deter-
mine the cost impact of obtaining emergency contracep-
tion directly from a pharmacist in Washington state. 
METHODS: Using a range of published rates of concep-
tion and emergency contraceptive effectiveness, the num-
ber of pregnancies prevented was estimated for 6267
women obtaining emergency contraception from a phar-
macist in Washington state from February 25, 1998 to
December 31, 1998. The direct costs of the prevented
pregnancies were estimated using published data updated
to 1998 dollars for private and public payers. Both an
averted-birth and a delayed-birth assumption were em-
ployed. Resulting costs were compared to the cost of the
emergency contraception to assess the cost impact. 
RESULTS: In the base case, emergency contraception
prevented 334 pregnancies. In the public payer, averted-
birth model, use of emergency contraception resulted in
$482,851 saved. The public payer, delayed-birth model
resulted in cost savings of $123,801. In the private payer,
averted-birth model, emergency contraception resulted in
cost savings of $1,511,382. The private payer, delayed-
birth model resulted in cost savings of $552,134. When
analyzing the best and worst case scenarios, savings from
use of emergency contraception ranged from $107,769
to $7,430,724. The broad range of cost savings is attrib-
utable to the heterogeneity of conception and effective-
ness rates assumed. 
CONCLUSION: Emergency contraception prevents many
unintended pregnancies. Under most assumptions, the di-
rect cost of emergency contraception is lower than the di-
rect cost of unintended pregnancies. Emergency contracep-
tion provided directly by pharmacists is a cost saving
method of preventing unintended pregnancies.
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Impairment of quality of life (QoL) of menopausal women
has often been demonstrated using condition-specific QoL
instruments. However, condition-specific QoL data are of
relatively limited usefulness in deciding whether treat-
ments of proven efficacy such as hormone replacement
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therapy (HRT) should be initiated in individual meno-
pausal women. 
OBJECTIVES: This research examined the correlations of
symptoms with the scores of a generic QoL instrument, the
Psychological General Well-Being Index (PGWBI). Correla-
tions were also examined between menopausal symptoms
and age. The subjects included 155 Italian menopausal
women who were either on HRT for less than 12 months
or were being considered for HRT. Menopausal symptoms
were measured by Kupperman’s index. 
RESULTS: Kupperman’s index correlated significantly
with the PGWBI global score (r  0.49; p  0.0001) and
all six domains (r  0.34 to 0.48; p  0.0001 for each).
By contrast, Age was not correlated with the PGWBI glo-
bal score (r  0.11; p  0.19) and PGWBI domains ex-
cept Depression with which a weak but significant corre-
lation was observed (r  0.16; p  0.05). Observed
differences in correlation suggest that menopausal symp-
toms are a major factor of impairment of QoL of women
independently of age. Though these findings confirm the
well-known association between impairment of the emo-
tional well-being and age, the latter did not reach signifi-
cance and was less than the association with menopausal
symptoms in this sample (r  0.16 versus r  0.47). 
CONCLUSION: These findings show that menopausal
symptoms are associated with impairment of general and
psychological well-being and QoL of women whereas age
is not necessarily associated with decline in general QoL.
Furthermore, severity of menopausal symptoms was found
to be more important for the emotional well-being of
women than age.
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OBJECTIVE: The purpose of this research was to explore
the relationships between the Nottingham Health Profile
(NHP) and clinical characteristics of patients with estab-
lished postmenopausal osteoporosis. The NHP is a ge-
neric, self-report health status measure consisting of 38
items comprising six domains: energy level, emotional re-
actions, physical mobility, pain, sleep, and social isolation. 
METHODS: Data were collected in the Multiple Out-
comes of Raloxifene Evaluation (MORE) study, a ran-
domized, placebo-controlled clinical trial of raloxifene in
7705 postmenopausal women who had low bone mineral
density (BMD) and/or prevalent vertebral fractures. Of
the MORE study subjects, 2545 completed the NHP.
This analysis was part of a substudy that evaluated the
baseline data of 781 subjects from various sites. Associa-
tions of NHP domain scores with age, femoral neck and
lumbar spine BMD, and number of nonvertebral and ver-
tebral fractures were estimated using Spearman correla-
tions. The relationships of NHP scores with the number
of nonvertebral and vertebral fractures were evaluated
using Kruskal-Wallis tests. 
RESULTS: Older subjects had lower levels of physical
mobility (p  0.0004). The number of nonvertebral frac-
tures was associated with less physical mobility (p 
0.0001) and greater pain (p  0.0194). The number of
vertebral fractures was associated with less physical mo-
bility (p  0.0001), more pain (p  0.0052), and lower
energy level (p  0.0285). 
CONCLUSIONS: These findings suggest that fractures in
patients with established postmenopausal osteoporosis
have a significant impact on health-related quality of life.
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Currently, no consensus has been reached in the field of
quality of life (QoL) research on the impact of meno-
pausal symptoms on QoL in aging women. Published
studies on relationships between menopausal estrogen
depletion and mental health status, using different mea-
surement approaches, have yielded conflicting findings. 
OBJECTIVE: The purpose of this study was to describe
quality of life (QoL) in Italian women with menopausal
symptoms compared to age-matched women from the
general Italian population. 
METHODS: Data were collected using baseline Psycho-
logical General Well-Being Index (PGWBI) scores from
155 women participating in a clinical trial and from 231
women participating in an epidemiological study. The
PGWBI is a well validated and widely used self-adminis-
tered instrument. The 22 items assess psychological and
general well-being of respondents in six QoL domains:
anxiety, depression, positive well-being, self-control, gen-
eral health, and vitality. The six subscale scores can be
summed to provide a global score. 
RESULTS: Overall, poorer psychological well-being scores
were reported by Italian women with menopausal symp-
toms compared to age-matched women from the general
Italian population. Significantly poorer scores were found
in the global score (p  0.0001) and in all six domains (p 
0.0001 for each) except general health (p  0.1537). 
CONCLUSION: The results of this study suggest that the
presence of menopausal symptoms in aging women is as-
sociated with an impaired quality of life in comparison to
the general female population. Additional research is
